News
Landmark Celebration of UBM India’s 11th edition of CPhI & P-MEC India gets underway today
UBM India, India's leading B2B exhibition organizer saw the launch of the grand 11th edition of the signature event, CPhI & P-MEC India 2017,...
News
Essentra will showcase its innovative pharmaceutical packaging, labels, serialisation and patient adherence solutions at CPhI India
Essentra, a global leader in healthcare packaging, will showcase its innovative pharmaceutical packaging, labels, serialisation and patient adherence solutions at CPhI India, 27-29th November...
Press Releases
Orchard Therapeutics Announces Extension of its Collaboration with Manchester University to Include Sanfilippo Syndrome Type B
Orchard Therapeutics Limited (“Orchard”), a clinical-stage biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies. ...
News
Tartu University Hospital expands Clinerion’s PRS network of hospitals into Estonia.
Tartu University Hospital, the only university hospital in Estonia and an e-Health pioneer, has joined the network of hospitals on Clinerion’s PRS platform. ...
News
Clinerion and iHealth Group partner with Bioserv SMO to accelerate clinical research in Brazil by introducing Clinerion’s PRS to the Hospital São Vicente de...
In concert with its Brazilian partner, the iHealth Group, Clinerion has agreed with Bioserv SMO to add Bioserv’s trial sites to the PRS platform....
Clinical Trials
OSE Immunotherapeutics to Resume Accrual in Phase 3 Clinical Trial of Tedopi® in Advanced Non-Small Cell Lung Cancer Patients Following Immune Checkpoint Inhibitor Treatment
OSE Immunotherapeutics announces that the Independent Data Monitoring Committee (IDMC) has recommended to the trial’s steering committee that accrual of the Tedopi® Phase 3...
Drug Research
Torque Launches Platform to Develop New Class of Deep Primed Immune Cell Therapies
Torque, an immuno-oncology company developing Deep Primed cell therapies that direct and evoke immune responses in the tumor microenvironment, announced the launch of its...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read